30 results on '"van den Tol, Petrousjka M."'
Search Results
2. Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival
- Author
-
Timmer, Florentine E.F., Geboers, Bart, Scheffer, Hester J., Bakker, Joyce, Ruarus, Alette H., Dijkstra, Madelon, van der Lei, Susan, Boon, Rianne, Nieuwenhuizen, Sanne, van den Bemd, Bente A.T., Schouten, Evelien A.C., van den Tol, Petrousjka M., Puijk, Robbert S., de Vries, Jan J.J., de Gruijl, Tanja D., and Meijerink, Martijn R.
- Published
- 2023
- Full Text
- View/download PDF
3. Implementation and outcome of minor and major minimally invasive liver surgery in the Netherlands
- Author
-
Zonderhuis, Babs, Rinkes, Inne B., Hoff, Christiaan, Oosterling, Steven, van der Poel, Marcel J., Fichtinger, Robert S., Bemelmans, Marc, Bosscha, Koop, Braat, Andries E., de Boer, Marieke T., Dejong, Cornelis H.C., Doornebosch, Pascal G., Draaisma, Werner A., Gerhards, Michael F., Gobardhan, Paul D., Gorgec, Burak, Hagendoorn, Jeroen, Kazemier, Geert, Klaase, Joost, Leclercq, Wouter K.G., Liem, Mike S., Lips, Daan J., Marsman, Hendrik A., Mieog, J. Sven D., Molenaar, Quintus I., Nieuwenhuijs, Vincent B., Nota, Carolijn L., Patijn, Gijs A., Rijken, Arjen M., Slooter, Gerrit D., Stommel, Martijn W.J., Swijnenburg, Rutger-Jan, Tanis, Pieter J., te Riele, Wouter W., Terkivatan, Türkan, van den Tol, Petrousjka M., van den Boezem, Peter B., van der Hoeven, Joost A., Vermaas, Maarten, Abu Hilal, Moh'd, van Dam, Ronald M., and Besselink, Marc G.
- Published
- 2019
- Full Text
- View/download PDF
4. Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts
- Author
-
Puijk, Robbert S., Ziedses des Plantes, Valentijn, Nieuwenhuizen, Sanne, Ruarus, Alette H., Vroomen, Laurien G. P. H., de Jong, Marcus C., Geboers, Bart, Hoedemaker-Boon, Caroline J., Thöne-Passchier, Deirdre H., Gerçek, Ceylan C., de Vries, Jan J. J., van den Tol, Petrousjka M. P., Scheffer, Hester J., and Meijerink, Martijn R.
- Published
- 2019
- Full Text
- View/download PDF
5. Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
- Author
-
van Pul, Kim M., Vuylsteke, Ronald J.C.L.M., van de Ven, Rieneke, te Velde, Elisabeth A., Rutgers, Emiel J. Th., van den Tol, Petrousjka M., Stockmann, Hein B.A.C., and de Gruijl, Tanja D.
- Published
- 2019
- Full Text
- View/download PDF
6. RF Ablation of Giant Hemangiomas Inducing Acute Renal Failure: A Report of Two Cases
- Author
-
van Tilborg, Aukje A. J. M., Dresselaars, Helena F., Scheffer, Hester J., Nielsen, Karin, Sietses, Colin, van den Tol, Petrousjka M., and Meijerink, Martijn R.
- Published
- 2016
- Full Text
- View/download PDF
7. Transcatheter CT Arterial Portography and CT Hepatic Arteriography for Liver Tumor Visualization during Percutaneous Ablation
- Author
-
van Tilborg, Aukje A.J.M., Scheffer, Hester J., Nielsen, Karin, van Waesberghe, Jan Hein T.M., Comans, Emile F., van Kuijk, C., van den Tol, Petrousjka M., and Meijerink, Martijn R.
- Published
- 2014
- Full Text
- View/download PDF
8. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial
- Author
-
Puijk, Robbert S., Ruarus, Alette H., Vroomen, Laurien G. P. H., van Tilborg, Aukje A. J. M., Scheffer, Hester J., Nielsen, Karin, de Jong, Marcus C., de Vries, Jan J. J., Zonderhuis, Babs M., Eker, Hasan H., Kazemier, Geert, Verheul, Henk, van der Meijs, Bram B., van Dam, Laura, Sorgedrager, Natasha, Coupé, Veerle M. H., van den Tol, Petrousjka M. P., Meijerink, Martijn R., and COLLISION Trial Group
- Published
- 2018
- Full Text
- View/download PDF
9. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts
- Author
-
van Tilborg, Aukje A. J. M., Scheffer, Hester J., de Jong, Marcus C., Vroomen, Laurien G. P. H., Nielsen, Karin, van Kuijk, Cornelis, van den Tol, Petrousjka M. P., and Meijerink, Martijn R.
- Published
- 2016
- Full Text
- View/download PDF
10. Viable Tumor Tissue Adherent to Needle Applicators after Local Ablation: A Risk Factor for Local Tumor Progression
- Author
-
Snoeren, Nikol, Huiskens, Joost, Rijken, Arjen M., van Hillegersberg, Richard, van Erkel, Arian R., Slooter, Gerrit D., Klaase, Joost M., van den Tol, Petrousjka M., Ten Kate, Fibo J. W., Jansen, Maarten C., and van Gulik, Thomas M.
- Published
- 2011
- Full Text
- View/download PDF
11. Transcatheter CT Hepatic Arteriography–Guided Percutaneous Ablation to Treat Ablation Site Recurrences of Colorectal Liver Metastases: The Incomplete Ring Sign
- Author
-
van Tilborg, Aukje A.J.M., Scheffer, Hester J., van der Meijs, Bram B., van Werkum, Michiel H., Melenhorst, Marleen C.A.M., van den Tol, Petrousjka M., and Meijerink, Martijn R.
- Published
- 2015
- Full Text
- View/download PDF
12. Breast‐specific factors determine cosmetic outcome and patient satisfaction after breast‐conserving therapy: Results from the randomized COBALT study.
- Author
-
Volders, José H., Negenborn, Vera L., Haloua, Max H., Krekel, Nicole M. A., Jóźwiak, Katarzyna, Meijer, Sybren, and van den Tol, Petrousjka M.
- Published
- 2018
- Full Text
- View/download PDF
13. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
- Author
-
Tilborg, Aukje, Scheffer, Hester, Jong, Marcus, Vroomen, Laurien, Nielsen, Karin, Kuijk, Cornelis, Tol, Petrousjka, Meijerink, Martijn, van Tilborg, Aukje A J M, Scheffer, Hester J, de Jong, Marcus C, Vroomen, Laurien G P H, van Kuijk, Cornelis, van den Tol, Petrousjka M P, and Meijerink, Martijn R
- Abstract
Purpose: To retrospectively analyse the safety and efficacy of radiofrequency ablation (RFA) versus microwave ablation (MWA) in the treatment of unresectable colorectal liver metastases (CRLM) in proximity to large vessels and/or major bile ducts.Method and Materials: A database search was performed to include patients with unresectable histologically proven and/or (18)F-FDG-PET avid CRLM who were treated with RFA or MWA between January 2001 and September 2014 in a single centre. All lesions that were considered to have a peribiliary and/or perivascular location were included. Univariate logistic regression analysis was performed to assess the distribution of patient, tumour and procedure characteristics. Multivariate logistic regression was used to correct for potential confounders.Results: Two hundred and forty-three patients with 774 unresectable CRLM were ablated. One hundred and twenty-two patients (78 males; 44 females) had at least one perivascular or peribiliary lesion (n = 199). Primary efficacy rate of RFA was superior to MWA after 3 and 12 months of follow-up (P = 0.010 and P = 0.022); however, after multivariate analysis this difference was non-significant at 12 months (P = 0.078) and vanished after repeat ablations (P = 0.39). More CTCAE grade III complications occurred after MWA versus RFA (18.8 vs. 7.9 %; P = 0.094); biliary complications were especially common after peribiliary MWA (P = 0.002).Conclusion: For perivascular CRLM, RFA and MWA are both safe treatment options that appear equally effective. For peribiliary CRLM, MWA has a higher complication rate than RFA, with similar efficacy. Based on these results, it is advised to use RFA for lesions in the proximity of major bile ducts. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
14. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
- Author
-
Scheffer, Hester J., Vroomen, Laurien G. P. H., Nielsen, Karin, van Tilborg, Aukje A. J. M., Comans, Emile F. I., van Kuijk, Cornelis, van der Meijs, Bram B., van den Bergh, Janneke, van den Tol, Petrousjka M. P., and Meijerink, Martijn R.
- Subjects
COLON cancer treatment ,COLON cancer patients ,LIVER cancer ,ELECTROPORATION therapy ,ABLATION techniques ,DISEASE progression ,CLINICAL trials ,COLON tumors ,COMPARATIVE studies ,COMPUTED tomography ,CYTOLOGICAL techniques ,DEOXY sugars ,LIVER tumors ,RESEARCH methodology ,MEDICAL cooperation ,RADIOPHARMACEUTICALS ,RECTUM tumors ,RESEARCH ,SURVIVAL analysis (Biometry) ,EVALUATION research - Abstract
Background: Irreversible electroporation (IRE) is a novel image-guided tumor ablation technique that has shown promise for the ablation of lesions in proximity to vital structures such as blood vessels and bile ducts. The primary aim of the COLDFIRE-2 trial is to investigate the efficacy of IRE for unresectable, centrally located colorectal liver metastases (CRLM). Secondary outcomes are safety, technical success, and the accuracy of contrast-enhanced (ce)CT and (18)F-FDG PET-CT in the detection of local tumor progression (LTP).Methods/design: In this single-arm, multicenter phase II clinical trial, twenty-nine patients with (18)F-FDG PET-avid CRLM ≤ 3,5 cm will be prospectively included to undergo IRE of the respective lesion. All lesions must be unresectable and unsuitable for thermal ablation due to vicinity of vital structures. Technical success is based on ceMRI one day post-IRE. All complications related to the IRE procedure are registered. Follow-up consists of (18)F-FDG PET-CT and 4-phase liver CT at 3-monthly intervals during the first year of follow-up. Treatment efficacy is defined as the percentage of tumors successfully eradicated 12 months after the initial IRE procedure based on clinical follow-up using both imaging modalities, tumor marker and (if available) histopathology. To determine the accuracy of (18)F-FDG PET-CT and ceCT, both imaging modalities will be individually scored by two reviewers that are blinded for the final oncologic outcome.Discussion: To date, patients with a central CRLM unsuitable for resection or thermal ablation have no curative treatment option and are given palliative chemotherapy. For these patients, IRE may prove a life-saving treatment option. The results of the proposed trial may represent an important step towards the implementation of IRE for central liver tumors in the clinical setting.Trial Registration: Trial Registration Number: NCT02082782. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
15. Percutaneous Irreversible Electroporation of a Large Centrally Located Hepatocellular Adenoma in a Woman with a Pregnancy Wish.
- Author
-
Scheffer, Hester J, Melenhorst, Marleen C A M, van Tilborg, Aukje A J M, Nielsen, Karin, van Nieuwkerk, Karin M, de Vries, Richard A, van den Tol, Petrousjka M P, and Meijerink, Martijn R
- Abstract
Irreversible electroporation (IRE) is a novel image-guided ablation technique that is rapidly gaining popularity in the treatment of malignant liver tumors located near large vessels or bile ducts. We describe a 28-year-old female patient with a 5 cm large, centrally located hepatocellular adenoma who wished to get pregnant. Regarding the risk of growth and rupture of the adenoma caused by hormonal changes during pregnancy, treatment of the tumor was advised prior to pregnancy. However, due to its central location, the tumor was considered unsuitable for resection and thermal ablation. Percutaneous CT-guided IRE was performed without complications and led to rapid and impressive tumor shrinkage. Subsequent pregnancy and delivery went uncomplicated. This case report suggests that the indication for IRE may extend to the treatment of benign liver tumors that cannot be treated safely otherwise. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
16. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
- Author
-
Nielsen, Karin, Scheffer, Hester J., Pieters', Indra C., van Tilborg, Aukje A. J. M., van Waesberghe, Jan-Hein T. M., Oprea-Lager, Daniela E., Meijerink, Martijn R., Kazemier, Geert, Hoekstra, Otto S., Schreurs, Hermien W. H., Sietses, Colin, Meijer, Sybren, Comans, Emile F. I., and van den Tol, Petrousjka M. P.
- Abstract
Background: Thermal ablation of colorectal liver metastases (CRLM) may result in local progression, which generally appear within a year of treatment. As the timely diagnosis of this progression allows potentially curative local treatment, an optimal follow-up imaging strategy is essential. PET-MRI is a one potential imaging modality, combining the advantages of PET and MRI. The aim of this study is evaluate fluorine-18 deoxyglucose positron emission tomography (FDG) PET-MRI as a modality for detection of local tumor progression during the first year following thermal ablation, as compared to the current standard, FDG PET-CT. The ability of FDG PET-MRI to detect new intrahepatic lesions, and the extent to which FDG PET-MRI alters clinical management, inter-observer variability and patient preference will also be included as secondary outcomes. Methods/Design: Twenty patients undergoing treatment with radiofrequency or microwave ablation for (recurrent) CRLM will be included in this prospective trial. During the first year of follow-up, patients will be scanned at the VU University Medical Center at 3-monthly intervals using a 4-phase liver CT, FDG PET-CT and FDG PET-MRI. Patients treated with chemotherapy <6 weeks prior to scanning or with a contra-indication for MRI will be excluded. MRI will be performed using both whole body imaging (mDixon) and dedicated liver sequences, including diffusion-weighted imaging, T1 in-phase and opposed-phase, T2 and dynamic contrast-enhanced imaging. The results of all modalities will be scored by 4 individual reviewers and inter-observer agreement will be determined. The reference standard will be histology or clinical follow-up. A questionnaire regarding patients’ experience with both modalities will also be completed at the end of the follow-up year. Discussion: Improved treatment options for local site recurrences following CRLM ablation mean that accurate post-ablation staging is becoming increasingly important. The combination of the sensitivity of MRI as a detection method for small intrahepatic lesions with the ability of FDG PET to visualize enhanced metabolism at the ablation site suggests that FDG PET-MRI could potentially improve the accuracy of (early) detection of progressive disease, and thus allow swifter and more effective decision-making regarding appropriate treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
17. Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial).
- Author
-
Krekel, Nicole M. A., Zonderhuis, Barbara M., Schreurs, Hermien W. H., Cardozo, Alexander M. F. Lopes, Rijna, Herman, Veen, Henk van der, Muller, Sandra, Poortman, Pieter, de Widt, Louise, de Roos, Wilfred K., Bosch, Anne Marie, van Amerongen, Annette H. M. Taets, Bergers, Elisabeth, van der Linden, Mecheline H. M., de Klerk, Elly S. M. de Lange, Winters, Henri A. H., Meijer, Sybren, and van den Tol, Petrousjka M. P.
- Subjects
BREAST cancer surgery ,CANCER patients ,SURGICAL excision ,DIAGNOSTIC ultrasonic imaging ,CYSTS (Pathology) - Abstract
Background: Breast-conserving surgery for breast cancer was developed as a method to preserve healthy breast tissue, thereby improving cosmetic outcomes. Thus far, the primary aim of breast-conserving surgery has been the achievement of tumour-free resection margins and prevention of local recurrence, whereas the cosmetic outcome has been considered less important. Large studies have reported poor cosmetic outcomes in 20-40% of patients after breast-conserving surgery, with the volume of the resected breast tissue being the major determinant. There is clear evidence for the efficacy of ultrasonography in the resection of nonpalpable tumours. Surgical resection of palpable breast cancer is performed with guidance by intra-operative palpation. These palpation-guided excisions often result in an unnecessarily wide resection of adjacent healthy breast tissue, while the rate of tumour-involved resection margins is still high. It is hypothesised that the use of intra-operative ultrasonography in the excision of palpable breast cancer will improve the ability to spare healthy breast tissue while maintaining or even improving the oncological margin status. The aim of this study is to compare ultrasound-guided surgery for palpable tumours with the standard palpation-guided surgery in terms of the extent of healthy breast tissue resection, the percentage of tumour-free margins, cosmetic outcomes and quality of life. Methods/design: In this prospective multicentre randomised controlled clinical trial, 120 women who have been diagnosed with palpable early-stage (T1-2N0-1) primary invasive breast cancer and deemed suitable for breastconserving surgery will be randomised between ultrasound-guided surgery and palpation-guided surgery. With this sample size, an expected 20% reduction of resected breast tissue and an 18% difference in tumour-free margins can be detected with a power of 80%. Secondary endpoints include cosmetic outcomes and quality of life. The rationale, study design and planned analyses are described. Conclusion: The COBALT trial is a prospective, multicentre, randomised controlled study to assess the efficacy of ultrasound-guided breast-conserving surgery in patients with palpable early-stage primary invasive breast cancer in terms of the sparing of breast tissue, oncological margin status, cosmetic outcomes and quality of life. Trial Registration Number: Netherlands Trial Register (NTR): NTR2579 [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
18. Assessment of Viable Tumour Tissue Attached to Needle Applicators after Local Ablation of Liver Tumours.
- Author
-
Snoeren, Nikol, Jansen, Maarten C., Rijken, Arjen M., Van Hillegersberg, Richard, Slooter, Gerrit, Klaase, Joost, Van den Tol, Petrousjka M., Van der Linden, Edwin, Ten Kate, Fibo J. W., and Van Gulik, Thomas M.
- Subjects
CANCER cells ,LIVER tumors ,LIVER cancer ,CANCER patients ,RADIO frequency ,CATHETER ablation ,MEDICAL lasers - Abstract
Aim: Local recurrence and needle track seeding are serious complications after local ablation for liver malignancies and potentially affect long-term survival. The aim of this study was to assess the incidence of viable tissue adherent to the needle applicators after ablation to gain insight into the possible mechanisms of local recurrence and needle track seeding. Methods: A total of 40 consecutive patients underwent 59 local liver ablations. Cells and tissue attached to the needle applicators were analysed for morphology (HE, PAP and Giemsa staining) and viability (G6PD staining). Results: Macroscopic tissue adherence was visible following 31 of the ablative procedures, all with radiofrequency ablation. Four applications were performed percutaneously and 27 during an open procedure. Morphologically intact tumour cells could be identified in 8 patients (20%), and viable tumour cells in 5 patients (12.5%). Morphologically intact tumour cells or viable tumour cells could only be demonstrated when track ablation was not performed. Conclusion: Viable tumour cells adherent to the needle applicators were found in an alarming 12.5% of patients after local ablation. We recommend track ablation not only after the procedure but also during any shifting and (re-)positioning to prevent shedding of viable tumour cells during or after ablation. Copyright © 2009 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
19. Mathematical 3D Liver Model for Surgical versus Ablative Therapy Treatment Planning for Colorectal Liver Metastases: Recommendations from the COLLISION and COLDFIRE Trial Expert Panels.
- Author
-
van den Bemd BAT, Puijk RS, Keijzers H, van den Tol PM, and Meijerink MR
- Subjects
- Humans, Female, Male, Aged, Middle Aged, Prospective Studies, Aged, 80 and over, Adult, Imaging, Three-Dimensional methods, Hepatectomy methods, Models, Theoretical, Liver surgery, Liver diagnostic imaging, Liver pathology, Colorectal Neoplasms pathology, Colorectal Neoplasms surgery, Liver Neoplasms secondary, Liver Neoplasms surgery, Liver Neoplasms diagnostic imaging, Ablation Techniques methods
- Abstract
Purpose To further define anatomic criteria for resection and ablation using an expert panel-based three-dimensional liver model to objectively predict local treatment recommendations for colorectal liver metastases (CRLM). Materials and Methods This study analyzed data from participants with small CRLM (≤3 cm) considered suitable for resection, thermal ablation, or irreversible electroporation (IRE), according to a multidisciplinary expert panel, who were included in two prospective multicenter trials (COLLISION [NCT03088150] and COLDFIRE-2 [NCT02082782]) between August 2017 and June 2022. Ten randomly selected participants were used to standardize the model's Couinaud segments. CRLM coordinates were measured and plotted in the model as color-coded lesions according to the treatment recommendations. Statistical validation was achieved through leave-one-out cross-validation. Results A total of 611 CRLM in 202 participants (mean age, 63 [range, 29-87] years; 138 male and 64 female) were included. Superficially located CRLM were considered suitable for resection, whereas more deep-seated CRLM were preferably ablated, with the transition zone at a subsurface depth of 3 cm. Ninety-three percent (25 of 27) of perihilar CRLM treated with IRE were at least partially located within 1 cm from the portal triad. Use of the model correctly predicted the preferred treatment in 313 of 424 CRLM (73.8%). Conclusion The results suggest that CRLM can be defined as superficial (preferably resected) and deep-seated (preferably ablated) if the tumor center is within versus beyond 3 cm from the liver surface, respectively, and as perihilar if the tumor margins extend to within 1 cm from the portal triad. Keywords: Ablation Techniques, CT, MRI, Liver, Abdomen/GI, Metastases, Oncology Supplemental material is available for this article. © RSNA, 2024.
- Published
- 2024
- Full Text
- View/download PDF
20. [Irreversible electroporation: local tumor ablation with systemic immune effect].
- Author
-
Geboers B, Timmer FEF, van den Tol PM, de Gruijl TD, Scheffer HJ, and Meijerink MR
- Subjects
- Electroporation, Humans, Immunotherapy, Male, Prospective Studies, Ablation Techniques, Liver Neoplasms therapy
- Abstract
Irreversible electroporation (IRE) employs high-voltage electrical pulses for non-thermal image-guided tumor ablation in solid organs. The pulses disrupt the membrane potential of all cells within the ablation zone causing loss of tumour cell homeostasis resulting in death. IRE has the advantage of sparing extracellular matrix structures and thereby preserving the anatomical integrity of blood vessels, bile ducts, and ureters. This trait distinguishes IRE from more commonly used thermal ablation techniques like microwave- and radiofrequency ablation. Several prospective phase-1 and -2 studies demonstrated the safety and efficacy of IRE for the treatment of central liver, locally advanced pancreatic, and local prostate tumours. In addition, IRE induces a systemic immune response. When this immune effect can be amplified by combinatory treatment with immunotherapeutic drugs its synergy might form a bridge between local and systemic therapies with the potential to develop into a fundamentally new approach to cancer treatment.
- Published
- 2021
21. Transcatheter CT Hepatic Arteriography Compared with Conventional CT Fluoroscopy Guidance in Percutaneous Thermal Ablation to Treat Colorectal Liver Metastases: A Single-Center Comparative Analysis of 2 Historical Cohorts.
- Author
-
Puijk RS, Nieuwenhuizen S, van den Bemd BAT, Ruarus AH, Geboers B, Vroomen LGPH, Muglia R, de Jong MC, de Vries JJJ, Scheffer HJ, van den Tol PMP, and Meijerink MR
- Subjects
- Aged, Colorectal Neoplasms mortality, Female, Fluoroscopy, Humans, Liver Neoplasms diagnostic imaging, Liver Neoplasms mortality, Liver Neoplasms secondary, Male, Middle Aged, Netherlands, Operative Time, Progression-Free Survival, Registries, Retrospective Studies, Risk Factors, Time Factors, Ablation Techniques adverse effects, Ablation Techniques mortality, Colorectal Neoplasms pathology, Computed Tomography Angiography adverse effects, Computed Tomography Angiography mortality, Liver Neoplasms surgery, Radiography, Interventional adverse effects, Radiography, Interventional mortality
- Abstract
Purpose: To evaluate safety and efficacy of CT hepatic arteriography compared with conventional CT fluoroscopy guidance in percutaneous radiofrequency (RF) and microwave (MW) ablation to treat colorectal liver metastases (CRLM)., Materials and Methods: This single-center comparative, retrospective study analyzed data of 108 patients treated with 156 percutaneous ablation procedures (42 CT fluoroscopy guidance [25 RF ablation, 17 MW ablation]; 114 CT hepatic arteriography guidance [18 RF ablation, 96 MW ablation]) for 260 CRLM between January 2009 and May 2019. Local tumor progression-free survival (LTPFS) was assessed using univariate and multivariate Cox proportional hazard regression analyses. LTPFS and overall survival (OS) were estimated using the Kaplan-Meier method., Results: There were no complications related to the transarterial catheter procedure. CT hepatic arteriography proved superior to CT fluoroscopy regarding 2-year LTPFS (18/202 [8.9%] vs 19/58 [32.8%]; P < .001, respectively). CT hepatic arteriography versus CT fluoroscopy (hazard ratio = 0.28; 95% confidence interval, 0.15-0.54; P < .001) and MW ablation versus RF ablation (hazard ratio = 0.52; 95% confidence interval, 0.24-1.12; P = .094) were positive predictors for longer LTPFS. Multivariate analysis revealed that CT hepatic arteriography versus CT fluoroscopy (hazard ratio = 0.41; 95% confidence interval, 0.19-0.90; P = .025) was associated with a significantly superior LTPFS. OS was similar between the 2 cohorts (P = .3)., Conclusions: While adding procedure time and marginal patient burden, transcatheter CT hepatic arteriography-guided ablation was associated with increased local disease control and superior LTPFS compared with conventional CT fluoroscopy. CT hepatic arteriography represents a safe and valid alternative to CT fluoroscopy, as it reduces the number of repeat ablations required without adding risk or detrimental effect on survival., (Copyright © 2020 SIR. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
22. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group.
- Author
-
Nieuwenhuizen S, Puijk RS, van den Bemd B, Aldrighetti L, Arntz M, van den Boezem PB, Bruynzeel AME, Burgmans MC, de Cobelli F, Coolsen MME, Dejong CHC, Derks S, Diederik A, van Duijvendijk P, Eker HH, Engelsman AF, Erdmann JI, Fütterer JJ, Geboers B, Groot G, Haasbeek CJA, Janssen JJ, de Jong KP, Kater GM, Kazemier G, Kruimer JWH, Leclercq WKG, van der Leij C, Manusama ER, Meier MAJ, van der Meijs BB, Melenhorst MCAM, Nielsen K, Nijkamp MW, Potters FH, Prevoo W, Rietema FJ, Ruarus AH, Ruiter SJS, Schouten EAC, Serafino GP, Sietses C, Swijnenburg RJ, Timmer FEF, Versteeg KS, Vink T, de Vries JJJ, de Wilt JHW, Zonderhuis BM, Scheffer HJ, van den Tol PMP, and Meijerink MR
- Abstract
The guidelines for metastatic colorectal cancer crudely state that the best local treatment should be selected from a 'toolbox' of techniques according to patient- and treatment-related factors. We created an interdisciplinary, consensus-based algorithm with specific resectability and ablatability criteria for the treatment of colorectal liver metastases (CRLM). To pursue consensus, members of the multidisciplinary COLLISION and COLDFIRE trial expert panel employed the RAND appropriateness method (RAM). Statements regarding patient, disease, tumor and treatment characteristics were categorized as appropriate, equipoise or inappropriate. Patients with ECOG≤2, ASA≤3 and Charlson comorbidity index ≤8 should be considered fit for curative-intent local therapy. When easily resectable and/or ablatable (stage IVa), (neo)adjuvant systemic therapy is not indicated. When requiring major hepatectomy (stage IVb), neo-adjuvant systemic therapy is appropriate for early metachronous disease and to reduce procedural risk. To downstage patients (stage IVc), downsizing induction systemic therapy and/or future remnant augmentation is advised. Disease can only be deemed permanently unsuitable for local therapy if downstaging failed (stage IVd). Liver resection remains the gold standard. Thermal ablation is reserved for unresectable CRLM, deep-seated resectable CRLM and can be considered when patients are in poor health. Irreversible electroporation and stereotactic body radiotherapy can be considered for unresectable perihilar and perivascular CRLM 0-5cm. This consensus document provides per-patient and per-tumor resectability and ablatability criteria for the treatment of CRLM. These criteria are intended to aid tumor board discussions, improve consistency when designing prospective trials and advance intersociety communications. Areas where consensus is lacking warrant future comparative studies.
- Published
- 2020
- Full Text
- View/download PDF
23. High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy.
- Author
-
Geboers B, Scheffer HJ, Graybill PM, Ruarus AH, Nieuwenhuizen S, Puijk RS, van den Tol PM, Davalos RV, Rubinsky B, de Gruijl TD, Miklavčič D, and Meijerink MR
- Subjects
- Antineoplastic Agents administration & dosage, Cell Fusion methods, Electric Stimulation Therapy methods, Electrochemotherapy methods, Gene Transfer Techniques, Humans, Immunotherapy methods, Electroporation methods, Medical Oncology methods, Neoplasms therapy
- Abstract
This review summarizes the use of high-voltage electrical pulses (HVEPs) in clinical oncology to treat solid tumors with irreversible electroporation (IRE) and electrochemotherapy (ECT). HVEPs increase the membrane permeability of cells, a phenomenon known as electroporation. Unlike alternative ablative therapies, electroporation does not affect the structural integrity of surrounding tissue, thereby enabling tumors in the vicinity of vital structures to be treated. IRE uses HVEPs to cause cell death by inducing membrane disruption, and it is primarily used as a radical ablative therapy in the treatment of soft-tissue tumors in the liver, kidney, prostate, and pancreas. ECT uses HVEPs to transiently increase membrane permeability, enhancing cellular cytotoxic drug uptake in tumors. IRE and ECT show immunogenic effects that could be augmented when combined with immunomodulatory drugs, a combination therapy the authors term electroimmunotherapy . Additional electroporation-based technologies that may reach clinical importance, such as gene electrotransfer, electrofusion, and electroimmunotherapy, are concisely reviewed. HVEPs represent a substantial advancement in cancer research, and continued improvement and implementation of these presented technologies will require close collaboration between engineers, interventional radiologists, medical oncologists, and immuno-oncologists., (© RSNA, 2020.)
- Published
- 2020
- Full Text
- View/download PDF
24. Implementation and outcome of minor and major minimally invasive liver surgery in the Netherlands.
- Author
-
van der Poel MJ, Fichtinger RS, Bemelmans M, Bosscha K, Braat AE, de Boer MT, Dejong CHC, Doornebosch PG, Draaisma WA, Gerhards MF, Gobardhan PD, Gorgec B, Hagendoorn J, Kazemier G, Klaase J, Leclercq WKG, Liem MS, Lips DJ, Marsman HA, Mieog JSD, Molenaar QI, Nieuwenhuijs VB, Nota CL, Patijn GA, Rijken AM, Slooter GD, Stommel MWJ, Swijnenburg RJ, Tanis PJ, Te Riele WW, Terkivatan T, van den Tol PM, van den Boezem PB, van der Hoeven JA, Vermaas M, Abu Hilal M, van Dam RM, and Besselink MG
- Subjects
- Aged, Attitude of Health Personnel, Conversion to Open Surgery statistics & numerical data, Female, Humans, Learning Curve, Male, Middle Aged, Netherlands epidemiology, Operative Time, Postoperative Complications epidemiology, Retrospective Studies, Surgeons, Surveys and Questionnaires, Hepatectomy statistics & numerical data, Laparoscopy statistics & numerical data, Liver surgery, Robotic Surgical Procedures statistics & numerical data
- Abstract
Background: While most of the evidence on minimally invasive liver surgery (MILS) is derived from expert centers, nationwide outcomes remain underreported. This study aimed to evaluate the implementation and outcome of MILS on a nationwide scale., Methods: Electronic patient files were reviewed in all Dutch liver surgery centers and all patients undergoing MILS between 2011 and 2016 were selected. Operative outcomes were stratified based on extent of the resection and annual MILS volume., Results: Overall, 6951 liver resections were included, with a median annual volume of 50 resections per center. The overall use of MILS was 13% (n = 916), which varied from 3% to 36% (P < 0.001) between centers. The nationwide use of MILS increased from 6% in 2011 to 23% in 2016 (P < 0.001). Outcomes of minor MILS were comparable with international studies (conversion 0-13%, mortality <1%). In centers which performed ≥20 MILS annually, major MILS was associated with less conversions (14 (11%) versus 41 (30%), P < 0.001), shorter operating time (184 (117-239) versus 200 (139-308) minutes, P = 0.010), and less overall complications (37 (30%) versus 58 (42%), P = 0.040)., Conclusion: The nationwide use of MILS is increasing, although large variation remains between centers. Outcomes of major MILS are better in centers with higher volumes., (Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
25. COLLISION Trial Seeks to Answer Time-Honored Question: "Thermal Ablation or Surgery for Colorectal Liver Metastases?"
- Author
-
Meijerink MR, Puijk RS, and van den Tol PMP
- Published
- 2019
- Full Text
- View/download PDF
26. Percutaneous Liver Tumour Ablation: Image Guidance, Endpoint Assessment, and Quality Control.
- Author
-
Puijk RS, Ruarus AH, Scheffer HJ, Vroomen LGPH, van Tilborg AAJM, de Vries JJJ, Berger FH, van den Tol PMP, and Meijerink MR
- Subjects
- Humans, Liver diagnostic imaging, Liver surgery, Treatment Outcome, Ablation Techniques methods, Liver Neoplasms diagnostic imaging, Liver Neoplasms surgery, Quality Control, Radiology, Interventional methods
- Abstract
Liver tumour ablation nowadays represents a routine treatment option for patients with primary and secondary liver tumours. Radiofrequency ablation and microwave ablation are the most widely adopted methods, although novel techniques, such as irreversible electroporation, are quickly working their way up. The percutaneous approach is rapidly gaining popularity because of its minimally invasive character, low complication rate, good efficacy rate, and repeatability. However, matched to partial hepatectomy and open ablations, the issue of ablation site recurrences remains unresolved and necessitates further improvement. For percutaneous liver tumour ablation, several real-time imaging modalities are available to improve tumour visibility, detect surrounding critical structures, guide applicators, monitor treatment effect, and, if necessary, adapt or repeat energy delivery. Known predictors for success are tumour size, location, lesion conspicuity, tumour-free margin, and operator experience. The implementation of reliable endpoints to assess treatment efficacy allows for completion-procedures, either within the same session or within a couple of weeks after the procedure. Although the effect on overall survival may be trivial, (local) progression-free survival will indisputably improve with the implementation of reliable endpoints. This article reviews the available needle navigation techniques, evaluates potential treatment endpoints, and proposes an algorithm for quality control after the procedure., (Copyright © 2017 Canadian Association of Radiologists. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
27. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
- Author
-
Scheffer HJ, Vroomen LG, de Jong MC, Melenhorst MC, Zonderhuis BM, Daams F, Vogel JA, Besselink MG, van Kuijk C, Witvliet J, de van der Schueren MA, de Gruijl TD, Stam AG, van den Tol PM, van Delft F, Kazemier G, and Meijerink MR
- Subjects
- Adult, Aged, Disease Progression, Female, Humans, Male, Middle Aged, Pain Measurement, Patient Safety, Prospective Studies, Quality of Life, Surveys and Questionnaires, Survival Rate, Treatment Outcome, Electroporation methods, Pancreatic Neoplasms therapy, Radiography, Interventional, Tomography, X-Ray Computed
- Abstract
Purpose To (a) investigate the safety of percutaneous irreversible electroporation (IRE) for locally advanced pancreatic cancer and (b) evaluate the quality of life (QOL), pain perception, and efficacy in terms of time to local progression, event-free survival, and overall survival (OS). Materials and Methods The study was approved by the local review board (NL42888.029.13). All patients provided written informed consent for study participation, the ablation procedure, and data usage. Between January 2014 and June 2015, 25 patients with histologically proved locally advanced pancreatic cancer 5 cm or smaller (13 women, 12 men; median age, 61 years; age range, 41-78 years) were prospectively included to undergo percutaneous computed tomographic-guided IRE. Patients with a metallic biliary Wallstent, epilepsy, or ventricular arrhythmias were excluded. Kaplan-Meier estimates were used to investigate time to local progression, event-free survival, and OS. Safety was assessed on the basis of adverse events, which were graded according to the Common Terminology Criteria for Adverse Events. Pain perception and QOL were evaluated by using specific questionnaires. Results All patients underwent IRE. The median largest tumor diameter was 4.0 cm (range, 3.3-5.0 cm). After a median follow-up of 12 months (interquartile range: 7-16 months), median event-free survival after IRE was 8 months (95% confidence interval [CI]: 4 months, 12 months); the median time to local progression after IRE was 12 months (95% CI: 8 months, 16 months). The median OS was 11 months from IRE (95% CI: 9 months, 13 months) and 17 months from diagnosis (95% CI: 10 months, 24 months). There were 12 minor complications (grade I or II) and 11 major complications (nine grade III, two grade IV) in 10 patients. There were no deaths within 90 days after IRE. Conclusion Percutaneous IRE for locally advanced pancreatic cancer is generally well tolerated, although major adverse events can occur. Preliminary survival data are encouraging and support the setup of larger phase II and III clinical trials to assess the efficacy of IRE plus chemotherapy in the neoadjuvant and adjuvant or second-line setting compared with more widely adopted regimens such as chemotherapy and/or radiation therapy.
© RSNA, 2016 Online supplemental material is available for this article.- Published
- 2017
- Full Text
- View/download PDF
28. Current status of ultrasound-guided surgery in the treatment of breast cancer.
- Author
-
Volders JH, Haloua MH, Krekel NM, Meijer S, and van den Tol PM
- Abstract
The primary goal of breast-conserving surgery (BCS) is to obtain tumour-free resection margins. Margins positive or focally positive for tumour cells are associated with a high risk of local recurrence, and in the case of tumour-positive margins, re-excision or even mastectomy are sometimes needed to achieve definite clear margins. Unfortunately, tumour-involved margins and re-excisions after lumpectomy are still reported in up to 40% of patients and additionally, unnecessary large excision volumes are described. A secondary goal of BCS is the cosmetic outcome and one of the main determinants of worse cosmetic outcome is a large excision volume. Up to 30% of unsatisfied cosmetic outcome is reported. Therefore, the search for better surgical techniques to improve margin status, excision volume and consequently, cosmetic outcome has continued. Nowadays, the most commonly used localization methods for BCS of non-palpable breast cancers are wire-guided localization (WGL) and radio-guided localization (RGL). WGL and RGL are invasive procedures that need to be performed pre-operatively with technical and scheduling difficulties. For palpable breast cancer, tumour excision is usually guided by tactile skills of the surgeon performing "blind" surgery. One of the surgical techniques pursuing the aims of radicality and small excision volumes includes intra-operative ultrasound (IOUS). The best evidence available demonstrates benefits of IOUS with a significantly high proportion of negative margins compared with other localization techniques in palpable and non-palpable breast cancer. Additionally, IOUS is non-invasive, easy to learn and can centralize the tumour in the excised specimen with low amount of healthy breast tissue being excised. This could lead to better cosmetic results of BCS. Despite the advantages of IOUS, only a small amount of surgeons are performing this technique. This review aims to highlight the position of ultrasound-guided surgery for malignant breast tumours in the search for better oncological and cosmetic outcomes.
- Published
- 2016
- Full Text
- View/download PDF
29. Irreversible Electroporation for Colorectal Liver Metastases.
- Author
-
Scheffer HJ, Melenhorst MC, Echenique AM, Nielsen K, van Tilborg AA, van den Bos W, Vroomen LG, van den Tol PM, and Meijerink MR
- Subjects
- Cell Death, Electroporation instrumentation, Equipment Design, Humans, Liver Neoplasms secondary, Positron-Emission Tomography, Postoperative Complications etiology, Risk Factors, Surgery, Computer-Assisted adverse effects, Surgery, Computer-Assisted instrumentation, Tomography, X-Ray Computed, Treatment Outcome, Ablation Techniques adverse effects, Ablation Techniques instrumentation, Colorectal Neoplasms pathology, Electroporation methods, Liver Neoplasms surgery, Surgery, Computer-Assisted methods
- Abstract
Image-guided tumor ablation techniques have significantly broadened the treatment possibilities for primary and secondary hepatic malignancies. A new ablation technique, irreversible electroporation (IRE), was recently added to the treatment armamentarium. As opposed to thermal ablation, cell death with IRE is primarily induced using electrical energy: electrical pulses disrupt the cellular membrane integrity, resulting in cell death while sparing the extracellular matrix of sensitive structures such as the bile ducts, blood vessels, and bowel wall. The preservation of these structures makes IRE attractive for colorectal liver metastases (CRLM) that are unsuitable for resection and thermal ablation owing to their anatomical location. This review discusses different technical and practical issues of IRE for CRLM: the indications, patient preparations, procedural steps, and different "tricks of the trade" used to improve safety and efficacy of IRE. Imaging characteristics and early efficacy results are presented. Much is still unknown about the exact mechanism of cell death and about factors playing a crucial role in the extent of cell death. At this time, IRE for CRLM should only be reserved for small tumors that are truly unsuitable for resection or thermal ablation because of abutment of the portal triad or the venous pedicles., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
30. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
- Author
-
Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AA, Vieveen JM, Bouwman AR, Meijer S, van Kuijk C, van den Tol PM, and Meijerink MR
- Subjects
- Ablation Techniques adverse effects, Ablation Techniques mortality, Diffusion Magnetic Resonance Imaging, Humans, Multimodal Imaging, Neoplasms mortality, Neoplasms pathology, Positron-Emission Tomography, Postoperative Complications mortality, Predictive Value of Tests, Risk Factors, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Ablation Techniques methods, Electrochemotherapy adverse effects, Electrochemotherapy mortality, Neoplasms surgery
- Abstract
Purpose: To provide an overview of current clinical results of irreversible electroporation (IRE), a novel, nonthermal tumor ablation technique that uses electric pulses to induce cell death, while preserving structural integrity of bile ducts and vessels., Methods: All in-human literature on IRE reporting safety or efficacy or both was included. All adverse events were recorded. Tumor response on follow-up imaging from 3 months onward was evaluated., Results: In 16 studies, 221 patients had 325 tumors treated in liver (n = 129), pancreas (n = 69), kidney (n = 14), lung (n = 6), lesser pelvis (n = 1), and lymph node (n = 2). No major adverse events during IRE were reported. IRE caused only minor complications in the liver; however, three major complications were reported in the pancreas (bile leak [n = 2], portal vein thrombosis [n = 1]). Complete response at 3 months was 67%-100% for hepatic tumors (93%-100% for tumors o 3 cm). Pancreatic IRE combined with surgery led to prolonged survival compared with control patients (20 mo vs 13 mo) and significant pain reduction., Conclusions: In cases where other techniques are unsuitable, IRE is a promising modality for the ablation of tumors near bile ducts and blood vessels. This articles gives an extensive overview of the available evidence, which is limited in terms of quality and quantity. With the limitations of the evidence in mind, IRE of central liver tumors seems relatively safe without major complications, whereas complications after pancreatic IRE appear more severe. The available limited results for tumor control are generally good. Overall, the future of IRE for difficult-to-reach tumors appears promising., (Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.